Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Canada/MariTide
Purchase and availability checkMariTide in Canada

Can you buy MariTide in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. MariTide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Canada
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy MariTide in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. MariTide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for MariTide in Canada?

Resolve the exact identity of MariTide through Phase 2 dose-ranging study - NCT05669599 from ClinicalTrials.gov. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.

03

Does an online listing prove MariTide is authorized or available in Canada?

No. A page using the name MariTide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

MariTide clinical trials in Canada

7 study records currently list 82 locations in this country, including 45 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
7
Listed locations
82
Recruiting locations
45
Records with local recruiting sites
4
NCT07037433
Study-wide statusRecruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Listed locations
17
Recruiting locations
16
Registry update
2026-07-24
NCT07037459
Study-wide statusRecruiting

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Listed locations
21
Recruiting locations
21
Registry update
2026-07-02
NCT07225686
Study-wide statusRecruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Listed locations
4
Recruiting locations
4
Registry update
2026-06-12
NCT07226765
Study-wide statusRecruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Listed locations
4
Recruiting locations
4
Registry update
2026-06-12
NCT05669599
Study-wide statusCompleted

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Listed locations
5
Recruiting locations
0
Registry update
2026-01-20
NCT06858878
Study-wide statusActive, not recruiting

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Listed locations
19
Recruiting locations
0
Registry update
2025-12-31
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Canada, or keep MariTide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

MariTide in North America

MariTide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

MariTide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: Phase 2 dose-ranging study - NCT05669599 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Phase 2 dose-ranging study - NCT05669599

Phase 2 dose-ranging study - NCT05669599 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Phase 2 dose-ranging study - NCT05669599 ↗

Drug Product Database

Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug Product Database ↗

Choosing a safe online pharmacy

Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Choosing a safe online pharmacy ↗
Canada / Country guide

Canada market context.

Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.

  • Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
  • The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
  • Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the DIN

Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.

02

Verify the pharmacy

Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.

03

Separate research labels

Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05669599: Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes MellitusClinicalTrials.gov
02
Drug Product DatabaseHealth Canada
03
Choosing a safe online pharmacyHealth Canada
04
Unauthorized injectable peptide warningHealth Canada
05
MariTide study search in CanadaClinicalTrials.gov
06
NCT07037433: Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityClinicalTrials.gov
07
NCT07037459: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityClinicalTrials.gov
08
NCT07225686: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure TherapyClinicalTrials.gov
09
NCT07226765: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) TherapyClinicalTrials.gov
10
NCT06858878: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.